JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BITO, L. Z.
Right arrow Articles by DAWSON, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BITO, L. Z.
Right arrow Articles by DAWSON, J. M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 175, Issue 3, 673-684, 1970
Copyright © 1970 by American Society for Pharmacology and Experimental Therapeutics


THE SITE AND MECHANISM OF THE CONTROL OF CHOLINERGIC SENSITIVITY

LASZLO Z. BITO 1 and JOAN M. DAWSON 1

1 Department of Ophthalmology Research, College of Physicians and Surgeons, Columbia University, New York

Chronic topical anticholinesterase (anti-ChE) treatment of the eye decreases the miotic effectiveness of the anti-ChE agent itself and causes a marked subsensitivity to the miotic effects of cholinomimetic drugs. Parasympathetic denervation of the eye eliminates the miotic effects of anti-ChE agents and renders the iris supersensitive to cholinomimetics. Chronic anti-ChE treatment has no measurable effect on the sensitivity of parasympathetically denervated eyes to carbachol and piocarpine and facilitates rather than decreases their sensitivity to methacholine. Cholinergic subsensitivity can be induced in parasympathetically denervated eyes when a continuous local supply of acetyicholine is provided in these eyes by daily intravitreal deposition of acetylcholine throughout the period of pretreatment with the anti-ChE agent. Repeated intravitreal injections of hemicholinium-3 into normally innervated eyes leads to a partial supersensitivity to cholinomimetics, or minimizes the anti-ChE-induced subsensitivity. Reduction of central parasympathetic outflow to the iris by light deprivation prior to and throughout the anti-ChE treatment also minimizes the development of subsensitivity. Similar stimulus deprivation without anti-ChE treatment leads to the development of a partial supersensitivity to miotics which is somewhat lesser in extent than denervation supersensitivity. Exposure of cats to environmental lighting conditions of higher than normal intensity results in a pronounced shift to the right in the pilocarpine dose-response curve. It is concluded that the sensitivity of the iris sphincter to cholinomimetics is a continuous function which is controlled by the long-term local concentration of acetylcholine at the site of the target organ.

Submitted on March 30, 1970
Accepted on August 4, 1970




This article has been cited by other articles:


Home page
ScienceHome page
L. Z. Bito, M. J. Dawson, and L. Petrinovi\l=c`\
Cholinergic Sensitivity: Normal Variability as a Function of Stimulus Background
Science, May 7, 1971; 172(3983): 583 - 585.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics.